Elevation Oncology, Inc. (ELEV)
0.3650
-0.0079 (-2.12%)
Inactive · Last trade price on Jul 22, 2025

Patterson Companies Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Selling, General & Admin
16.2116.1114.915.838.451.8
Upgrade
Research & Development
29.4628.625.4378.7223.615.48
Upgrade
Operating Expenses
45.6844.740.3494.5532.0517.28
Upgrade
Operating Income
-45.68-44.7-40.34-94.55-32.05-17.28
Upgrade
Interest Expense
-3.87-4-4.13-1.5--
Upgrade
Interest & Investment Income
4.975.23.91--
Upgrade
Other Non Operating Income (Expenses)
----0.010.010.01
Upgrade
EBT Excluding Unusual Items
-44.58-43.5-40.57-95.06-32.04-17.27
Upgrade
Merger & Restructuring Charges
-3.38--5.11---
Upgrade
Other Unusual Items
--0.94----
Upgrade
Pretax Income
-47.95-44.44-45.67-95.06-32.04-17.27
Upgrade
Income Tax Expense
0.040.040.030.03--
Upgrade
Net Income
-47.99-44.49-45.7-95.08-32.04-17.27
Upgrade
Net Income to Common
-47.99-44.49-45.7-95.08-32.04-17.27
Upgrade
Shares Outstanding (Basic)
59573723121
Upgrade
Shares Outstanding (Diluted)
59573723121
Upgrade
Shares Change (YoY)
35.68%56.82%56.97%91.77%1432.24%6.43%
Upgrade
EPS (Basic)
-0.81-0.78-1.25-4.09-2.64-21.80
Upgrade
EPS (Diluted)
-0.81-0.78-1.25-4.09-2.64-21.80
Upgrade
Free Cash Flow
-39.5-36.36-56.18-85.57-30.17-12.37
Upgrade
Free Cash Flow Per Share
-0.67-0.64-1.54-3.68-2.49-15.62
Upgrade
EBITDA
-45.66-44.68-40.3-94.52-32.03-
Upgrade
D&A For EBITDA
0.020.020.040.030.02-
Upgrade
EBIT
-45.68-44.7-40.34-94.55-32.05-17.28
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q